When I first started writing BTP in the 1970s, it was to bridge the gap between new knowledge in our field and its application to patient care. Over the decades since, this need has become even greater. Neuroscience rockets forward. Psychiatrists, and other clinicians who treat patients with mental disorders, have a broader array of treatments than we even dreamed of back then. But we have less time to spend with patients and less time to keep up with the developments that affect treatment decisions. Our medications, and those prescribed by colleagues in other specialties, are more varied and complex—and prone to interactions. What were formerly crisp boundaries between major psychopharmacologic categories are now murky.

This makes the modern practice of psychiatry challenging—but also fun and promising. With the expanding armamentarium of treatment options comes enhanced ability to alleviate suffering. The mission of BTP remains constant, even while the field grows. We are still here to bridge the gap, to make science applicable and relevant, and to help you in your day-to-day work relieve distress and improve function in patients' lives.